James N. Fleming

Title
InstitutionMedical University of South Carolina
DepartmentCOP Clinical Pharmacy and Outcome Sciences - MUSC Campus
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Fleming JN, Cober T, Hickey J, Stach L, Kawano A, Szczepanik A, Watson A, Imamura Y, Weems J, West-Thielke P. Clinical Utility of the OmniGraf Biomarker Panel in the Care of Kidney Transplant Recipients (CLARITY): Protocol for a Prospective, Multisite Observational Study. JMIR Res Protoc. 2022 Dec 14; 11(12):e41020. PMID: 36515980.
      Citations:    
    2. Fleming JN, Pollock MD, Taber DJ, McGillicuddy JW, Diamantidis CJ, Docherty SL, Chambers ET, Fleming JN, Pollock MD, Taber DJ, McGillicuddy JW, Diamantidis CJ, Docherty SL, Chambers ET. Review and Evaluation of mHealth Apps in Solid Organ Transplantation: Past, Present, and Future. Transplant Direct. 2022 Mar; 8(3):e1298. PMID: 35368987; PMCID: PMC8966961.
      Citations: 2     
    3. Gonzales HM, Fleming JN, Gebregziabher M, Posadas Salas MA, McGillicuddy JW, Taber DJ, Gonzales HM, Fleming JN, Gebregziabher M, Posadas Salas MA, McGillicuddy JW, Taber DJ. A Critical Analysis of the Specific Pharmacist Interventions and Risk Assessments During the 12-Month TRANSAFE Rx Randomized Controlled Trial. Ann Pharmacother. 2022 06; 56(6):685-690. PMID: 34496669; PMCID: PMC8901797.
      Citations:    
    4. Taber DJ, Fleming JN, Su Z, Mauldin P, McGillicuddy JW, Posadas A, Gebregziabher M, Taber DJ, Fleming JN, Su Z, Mauldin P, McGillicuddy JW, Posadas A, Gebregziabher M. Significant hospitalization cost savings to the payer with a pharmacist-led mobile health intervention to improve medication safety in kidney transplant recipients. Am J Transplant. 2021 10; 21(10):3428-3435. PMID: 34197699.
      Citations:    
    5. Fleming JN, Gebregziabher M, Posadas A, Su Z, McGillicuddy JW, Taber DJ, Fleming JN, Gebregziabher M, Posadas A, Su Z, McGillicuddy JW, Taber DJ. Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: A report from the TRANSAFE Rx randomized controlled trial. Am J Health Syst Pharm. 2021 07 09; 78(14):1287-1293. PMID: 33821958; PMCID: PMC8599187.
      Citations:    
    6. Stoll WD, Mester RA, Fleming JN, Sirianni JM, Abro JA, Colhoun ED, Taber DJ, Hebbar L, Stoll WD, Mester RA, Fleming JN, Sirianni JM, Abro JA, Colhoun ED, Taber DJ, Hebbar L. Impact of Anesthesiologist Experience on Early Outcomes in Adult Orthotopic Liver Transplantation. Transplant Proc. 2021 Jun; 53(5):1665-1669. PMID: 34020795.
      Citations:    
    7. Gonzales HM, Fleming JN, Gebregziabher M, Posadas-Salas MA, Su Z, McGillicuddy JW, Taber DJ, Gonzales HM, Fleming JN, Gebregziabher M, Posadas-Salas MA, Su Z, McGillicuddy JW, Taber DJ. Pharmacist-Led Mobile Health Intervention and Transplant Medication Safety: A Randomized Controlled Clinical Trial. Clin J Am Soc Nephrol. 2021 05 08; 16(5):776-784. PMID: 33931415; PMCID: PMC8259471.
      Citations:    
    8. Wise B, Wilson LZ, Taber DJ, Pilch NA, Rohan V, Fleming JN, Wise B, Wilson LZ, Taber DJ, Pilch NA, Rohan V, Fleming JN. The impact of pretransplant opioid exposure on healthcare utilization and costs in kidney transplant. Pharmacotherapy. 2021 01; 41(1):6-13. PMID: 33107627.
      Citations:    
    9. Rohan VS, Taber DJ, Patel N, Perez C, Pilch N, Parks S, Bolin E, Nadig SN, Baliga PK, Fleming JN, Rohan VS, Taber DJ, Patel N, Perez C, Pilch N, Parks S, Bolin E, Nadig SN, Baliga PK, Fleming JN. Impact of a multidisciplinary multimodal opioid minimization initiative in kidney transplant recipients. Clin Transplant. 2020 10; 34(10):e14006. PMID: 32524643.
      Citations:    
    10. Fleming JN, Posadas Salas MA, Taber DJ, Fleming JN, Posadas Salas MA, Taber DJ. Dosing Requirements of Extended-Release Tacrolimus (Astagraf XL) in African American Kidney Transplant Recipients Converted from Immediate-Release Tacrolimus (AAAKTRS). Ther Drug Monit. 2020 06; 42(3):415-420. PMID: 31913864.
      Citations:    
    11. Taber DJ, Posadas-Salas A, Su Z, Rao V, Rohan V, Nadig S, McGillicuddy JW, Dubay D, Fleming JN, Taber DJ, Posadas-Salas A, Su Z, Rao V, Rohan V, Nadig S, McGillicuddy JW, Dubay D, Fleming JN. Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: Results of a randomized controlled pilot study. Clin Transplant. 2020 04; 34(4):e13844. PMID: 32092187.
      Citations:    
    12. Fleming JN, Zhang J, Taber DJ, McCauley JL, Schumann S, Mauldin PD, Ball S, Fleming JN, Zhang J, Taber DJ, McCauley JL, Schumann S, Mauldin PD, Ball S. The effect of targeted insurer-mandated prescription monitoring on opioid prescribing patterns. J Am Pharm Assoc (2003). 2020 Jul - Aug; 60(4):559-564. PMID: 32033899.
      Citations:    
    13. Taber DJ, Pilch NA, McGillicuddy JW, Mardis C, Treiber F, Fleming JN, Taber DJ, Pilch NA, McGillicuddy JW, Mardis C, Treiber F, Fleming JN. Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients. Am J Health Syst Pharm. 2019 Jul 18; 76(15):1143-1149. PMID: 31361870.
      Citations:    
    14. Taber DJ, Su Z, Fleming JN, Pilch NA, Morinelli T, Mauldin P, Dubay D, Taber DJ, Su Z, Fleming JN, Pilch NA, Morinelli T, Mauldin P, Dubay D. The impact of time-varying clinical surrogates on disparities in African-American kidney transplant recipients - a retrospective longitudinal cohort study. Transpl Int. 2019 01; 32(1):84-94. PMID: 30176087; PMCID: PMC6309248.
      Citations:    
    15. Pilch NA, Fleming JN, Crowther BR, Maldonado AQ, Taber DJ, Pilch NA, Fleming JN, Crowther BR, Maldonado AQ, Taber DJ. It is time for board certification in transplant pharmacotherapy. Am J Transplant. 2018 09; 18(9):2370-2371. PMID: 29856528.
      Citations:    
    16. Fleming JN, Treiber F, McGillicuddy J, Gebregziabher M, Taber DJ, Fleming JN, Treiber F, McGillicuddy J, Gebregziabher M, Taber DJ. Improving Transplant Medication Safety Through a Pharmacist-Empowered, Patient-Centered, mHealth-Based Intervention: TRANSAFE Rx Study Protocol. JMIR Res Protoc. 2018 Mar 02; 7(3):e59. PMID: 29500161; PMCID: PMC5856926.
      Citations:    
    17. Fleming JN, Taber DJ, Pilch NA, Mardis CR, Gilbert RE, Wilson LZ, Patel N, Ball S, Mauldin P, Baliga PK, Fleming JN, Taber DJ, Pilch NA, Mardis CR, Gilbert RE, Wilson LZ, Patel N, Ball S, Mauldin P, Baliga PK. Association of Pretransplantion Opioid Use with Graft Loss or Death in Liver Transplantation Patients with Model of End-Stage Liver Disease Exceptions. J Am Coll Surg. 2018 04; 226(4):651-659. PMID: 29309943.
      Citations:    
    18. Fleming JN, Taber DJ, Weimert NA, Nadig S, McGillicuddy JW, Bratton CF, Baliga PK, Chavin KD, Fleming JN, Taber DJ, Weimert NA, Nadig S, McGillicuddy JW, Bratton CF, Baliga PK, Chavin KD. Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200?days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study. Transpl Infect Dis. 2017 Dec; 19(6). PMID: 28921781.
      Citations:    
    19. Taber DJ, Su Z, Fleming JN, McGillicuddy JW, Posadas-Salas MA, Treiber FA, Dubay D, Srinivas TR, Mauldin PD, Moran WP, Baliga PK, Taber DJ, Su Z, Fleming JN, McGillicuddy JW, Posadas-Salas MA, Treiber FA, Dubay D, Srinivas TR, Mauldin PD, Moran WP, Baliga PK. Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation. Transplantation. 2017 12; 101(12):2931-2938. PMID: 28658199; PMCID: PMC5709143.
      Citations:    
    20. Fleming JN, Lai JC, Te HS, Said A, Spengler EK, Rogal SS, Fleming JN, Lai JC, Te HS, Said A, Spengler EK, Rogal SS. Opioid and opioid substitution therapy in liver transplant candidates: A survey of center policies and practices. Clin Transplant. 2017 Dec; 31(12). PMID: 28941292; PMCID: PMC6392463.
      Citations:    
    21. Spengler EK, O'Leary JG, Te HS, Rogal S, Pillai AA, Al-Osaimi A, Desai A, Fleming JN, Ganger D, Seetharam A, Tsoulfas G, Montenovo M, Lai JC, Spengler EK, O'Leary JG, Te HS, Rogal S, Pillai AA, Al-Osaimi A, Desai A, Fleming JN, Ganger D, Seetharam A, Tsoulfas G, Montenovo M, Lai JC. Liver Transplantation in the Obese Cirrhotic Patient. Transplantation. 2017 10; 101(10):2288-2296. PMID: 28930104; PMCID: PMC5762611.
      Citations:    
    22. Veasey TM, Fleming JN, Strout SE, Miller R, Pilch NA, Meadows HB, Mardis CR, Mardis BA, Shenvi S, McGillicuddy J, Chavin KD, Baliga P, Taber DJ, Veasey TM, Fleming JN, Strout SE, Miller R, Pilch NA, Meadows HB, Mardis CR, Mardis BA, Shenvi S, McGillicuddy J, Chavin KD, Baliga P, Taber DJ. Morbid obesity and functional status as predictors of surgical complication after renal transplantation. Am J Surg. 2018 Apr; 215(4):663-668. PMID: 28622834.
      Citations:    
    23. Casale JP, Taber DJ, Staino C, Boyle K, Covert K, Pilch NA, Mardis C, Meadows HB, Chavin KD, McGillicuddy JW, Baliga PK, Fleming JN, Casale JP, Taber DJ, Staino C, Boyle K, Covert K, Pilch NA, Mardis C, Meadows HB, Chavin KD, McGillicuddy JW, Baliga PK, Fleming JN. Effectiveness of an Evidence-Based Induction Therapy Protocol Revision in Adult Kidney Transplant Recipients. Pharmacotherapy. 2017 Jun; 37(6):692-699. PMID: 28475248.
      Citations:    
    24. Covert KL, Mardis CR, Fleming JN, Pilch NA, Meadows HB, Mardis BA, Mohan P, Posadas-Salas M, Srinivas T, Taber DJ, Covert KL, Mardis CR, Fleming JN, Pilch NA, Meadows HB, Mardis BA, Mohan P, Posadas-Salas M, Srinivas T, Taber DJ. Development of a Predictive Model for Drug-Related Problems in Kidney Transplant Recipients. Pharmacotherapy. 2017 02; 37(2):159-169. PMID: 27997676.
      Citations:    
    25. Taber DJ, Fleming JN, Fominaya CE, Gebregziabher M, Hunt KJ, Srinivas TR, Baliga PK, McGillicuddy JW, Egede LE, Taber DJ, Fleming JN, Fominaya CE, Gebregziabher M, Hunt KJ, Srinivas TR, Baliga PK, McGillicuddy JW, Egede LE. The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation. Am J Nephrol. 2017; 45(1):91-98. PMID: 27907919; PMCID: PMC5214896.
      Citations:    
    26. Fleming JN, Taber DJ, Pilch NA, Srinivas TR, Chavin KD, Fleming JN, Taber DJ, Pilch NA, Srinivas TR, Chavin KD. Yes, We Still Need IL-2 Receptor Antagonists. Am J Transplant. 2016 11; 16(11):3308-3309. PMID: 27321737.
      Citations:    
    27. Covert KL, Fleming JN, Staino C, Casale JP, Boyle KM, Pilch NA, Meadows HB, Mardis CR, McGillicuddy JW, Nadig S, Bratton CF, Chavin KD, Baliga PK, Taber DJ, Covert KL, Fleming JN, Staino C, Casale JP, Boyle KM, Pilch NA, Meadows HB, Mardis CR, McGillicuddy JW, Nadig S, Bratton CF, Chavin KD, Baliga PK, Taber DJ. Predicting and preventing readmissions in kidney transplant recipients. Clin Transplant. 2016 07; 30(7):779-86. PMID: 27101090.
      Citations:    
    28. Fleming JN, Taber DJ, Pilch NA, McGillicuddy JW, Srinivas TR, Baliga PK, Chavin KD, Bratton CF, Fleming JN, Taber DJ, Pilch NA, McGillicuddy JW, Srinivas TR, Baliga PK, Chavin KD, Bratton CF. A randomized, prospective comparison of transition to sirolimus-based CNI-minimization or withdrawal in African American kidney transplant recipients. Clin Transplant. 2016 05; 30(5):528-33. PMID: 26914542.
      Citations:    
    29. Morbitzer KA, Taber DJ, Pilch NA, Meadows HB, Fleming JN, Bratton CF, McGillicuddy JW, Baliga PK, Chavin KD, Morbitzer KA, Taber DJ, Pilch NA, Meadows HB, Fleming JN, Bratton CF, McGillicuddy JW, Baliga PK, Chavin KD. The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C. Clin Transplant. 2014 Aug; 28(8):862-8. PMID: 24893750.
      Citations:    
    30. Taber DJ, Spivey JR, Tsurutis VM, Pilch NA, Meadows HB, Fleming JN, McGillicuddy JW, Bratton CF, Treiber FA, Baliga PK, Chavin KD, Taber DJ, Spivey JR, Tsurutis VM, Pilch NA, Meadows HB, Fleming JN, McGillicuddy JW, Bratton CF, Treiber FA, Baliga PK, Chavin KD. Clinical and economic outcomes associated with medication errors in kidney transplantation. Clin J Am Soc Nephrol. 2014 May; 9(5):960-6. PMID: 24763866; PMCID: PMC4011453.
      Citations:    
    31. Rech MA, Fleming JN, Moore CL, Rech MA, Fleming JN, Moore CL. 25-hydroxyvitamin D deficiency and opportunistic viral infections after kidney transplant. Exp Clin Transplant. 2014 Apr; 12(2):95-100. PMID: 24702139.
      Citations:    
    32. Taber DJ, Srinivas TM, Pilch NA, Meadows HB, Fleming JN, McGillicuddy JW, Bratton CF, Thomas B, Chavin KD, Baliga PK, Egede LE, Taber DJ, Srinivas TM, Pilch NA, Meadows HB, Fleming JN, McGillicuddy JW, Bratton CF, Thomas B, Chavin KD, Baliga PK, Egede LE. Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients? Am J Nephrol. 2013; 38(4):285-91. PMID: 24061145.
      Citations:    
    33. Fleming JN, Malinzak L, Abouljoud M, Fleming JN, Malinzak L, Abouljoud M. Effect of standardized medication-order forms on medication errors after liver or kidney transplantation. Am J Health Syst Pharm. 2012 Jun 01; 69(11):916-7. PMID: 22610018.
      Citations:    
    34. Fleming JN, Weimert NA, Fleming JN, Weimert NA. Novel strategies for immune monitoring in kidney transplant recipients. Adv Chronic Kidney Dis. 2010 Sep; 17(5):e63-77. PMID: 20727505.
      Citations:    
    35. Fleming JN, Abou Abbass A, Fleming JN, Abou Abbass A. Hepatorenal syndrome: a comprehensive overview for the critical care nurse. Crit Care Nurs Clin North Am. 2010 Sep; 22(3):351-68. PMID: 20691386.
      Citations:    
    36. Fleming JN, Taber DJ, Weimert NA, Egidi MF, McGillicuddy J, Bratton CF, Lin A, Chavin KD, Baliga PK, Fleming JN, Taber DJ, Weimert NA, Egidi MF, McGillicuddy J, Bratton CF, Lin A, Chavin KD, Baliga PK. Comparison of efficacy of induction therapy in low immunologic risk African-American kidney transplant recipients. Transpl Int. 2010 May 01; 23(5):500-5. PMID: 19951304.
      Citations:    
    Fleming's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (167)
    Explore
    _
    Co-Authors (27)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _